Page last updated: 2024-10-27

gemfibrozil and Diabetic Angiopathies

gemfibrozil has been researched along with Diabetic Angiopathies in 14 studies

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research Excerpts

ExcerptRelevanceReference
"To assess the effect of insulin resistance and the benefit of the fibrate, gemfibrozil, on the incidence of major cardiovascular events in subjects with low HDL cholesterol and a broad range of triglyceride values who participated in the Veterans Affairs High Density Lipoprotein Intervention Trial (VA-HIT)."5.10Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). ( Anderson, JW; Collins, D; Elam, MB; Faas, FH; Robins, SJ; Rubins, HB; Schaefer, EJ, 2003)
"Disease progression is associated with variation in AAT, and low AAT levels promote atherogenesis."2.71Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. ( Flavell, DM; Frick, MH; Humphries, SE; Jackson, R; Kesäniemi, YA; Martin, S; Nagl, S; Nieminen, MS; Pasternack, A; Steiner, G; Syvänne, M; Talmud, PJ; Taskinen, MR; Whitehouse, DB, 2003)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (28.57)18.2507
2000's10 (71.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Talmud, PJ1
Martin, S1
Steiner, G1
Flavell, DM1
Whitehouse, DB1
Nagl, S1
Jackson, R1
Taskinen, MR1
Frick, MH1
Nieminen, MS1
Kesäniemi, YA1
Pasternack, A1
Humphries, SE1
Syvänne, M1
Robins, SJ1
Rubins, HB1
Faas, FH1
Schaefer, EJ1
Elam, MB1
Anderson, JW1
Collins, D1
Vajo, Z1
Reaven, PD1
Garber, AJ1
Boden, WE1
Sigal, R2
Malcolm, J2
Meggison, H1
Ganda, OP1
Patel, J1
Arnaout, A1
Brinton, EA1
Welborn, TA1
Górriz, JL1
Sancho, A1
Lopez-Martin, JM1
Alcoy, E1
Catalán, C1
Pallardó, LM1
Haffner, SM1
Fasching, P1
Ratheiser, K1
Waldhäusl, W1
Rohac, M1
Vierhapper, H1

Reviews

8 reviews available for gemfibrozil and Diabetic Angiopathies

ArticleYear
Cardiovascular complications of diabetes: prevention and management.
    Clinical cornerstone, 2003, Volume: 5, Issue:2

    Topics: Blood Pressure; Diabetic Angiopathies; Disease Progression; Gemfibrozil; Humans; Hydroxymethylglutar

2003
Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia management.
    Current opinion in cardiology, 2003, Volume: 18, Issue:4

    Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetic Angiopathies; Drug Thera

2003
Prevention of cardiovascular events in diabetes.
    Clinical evidence, 2004, Issue:11

    Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Corona

2004
The role of lipid management in diabetes.
    Cardiology clinics, 2005, Volume: 23, Issue:2

    Topics: Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus; Diabetic Angiopathies; Gemfibrozil; Hepta

2005
Dyslipidaemia in diabetes.
    Clinical evidence, 2006, Issue:15

    Topics: Azetidines; Bezafibrate; Diabetes Complications; Diabetic Angiopathies; Drug Therapy, Combination; D

2006
Prevention of cardiovascular events in diabetes.
    Clinical evidence, 2006, Issue:15

    Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Clopid

2006
Does the addition of fibrates to statin therapy have a favorable risk to benefit ratio?
    Current atherosclerosis reports, 2008, Volume: 10, Issue:1

    Topics: Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Clofibric Acid; Diabetic Angiopathies; D

2008
Dyslipidaemia in non-insulin dependent diabetes: the need for a clinical intervention trial.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:1

    Topics: Cholesterol, HDL; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diabetes Mellitus, Type 2;

1994

Trials

4 trials available for gemfibrozil and Diabetic Angiopathies

ArticleYear
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Apr-01, Volume: 23, Issue:4

    Topics: 3' Untranslated Regions; Aged; Alleles; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Amino A

2003
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
    Diabetes care, 2003, Volume: 26, Issue:5

    Topics: Body Constitution; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Diabetes Mellitus, Ty

2003
Managing lipid disorders: further evaluation of the VA-HIT.
    Current diabetes reports, 2003, Volume: 3, Issue:3

    Topics: Adult; Aged; Cholesterol, HDL; Coronary Disease; Diabetic Angiopathies; Gemfibrozil; Humans; Hypolip

2003
[Fish oil as lipostatic factor].
    VASA. Supplementum, 1990, Volume: 30

    Topics: Adult; Diabetic Angiopathies; Female; Fish Oils; Gemfibrozil; Humans; Hyperlipidemias; Lipids; Male;

1990

Other Studies

2 other studies available for gemfibrozil and Diabetic Angiopathies

ArticleYear
Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
    Nephron, 1996, Volume: 74, Issue:2

    Topics: Acute Kidney Injury; Aged; Angiotensin-Converting Enzyme Inhibitors; Bicarbonates; Diabetes Mellitus

1996
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Diabetes care, 1997, Volume: 20, Issue:4

    Topics: Anticholesteremic Agents; Cholesterol, HDL; Coronary Disease; Diabetic Angiopathies; Gemfibrozil; Hu

1997